These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of osteoporosis with parathyroid hormone].
    Author: Syversen U, Halse JI.
    Journal: Tidsskr Nor Laegeforen; 2008 Jan 03; 128(1):39-41. PubMed ID: 18183056.
    Abstract:
    BACKGROUND: Until recently, antiresorptive therapy has been the only treatment of osteoporosis. Parathyroid hormone (PTH) represents a new treatment principle. PTH given intermittently stimulates the osteoblasts and bone formation. We here present the effect of PTH on bone metabolism, bone mineral density and fracture reduction, and discuss the role of PTH in osteoporosis treatment. MATERIAL AND METHODS: The article is based on literature retrieved from Pubmed/Medline and on own experience from participation in multicentre studies. RESULTS AND INTERPRETATION: Treatment with PTH stimulates bone formation and causes a more pronounced increase in bone mineral density than bisphosphonates and results in a significant reduction of vertebral and nonvertebral fractures. The treatment is very expensive, and is therefore used and reimbursed restrictively.
    [Abstract] [Full Text] [Related] [New Search]